Results 221 to 230 of about 22,997 (249)

The Role of Fda's Orphan Products Development Program in the Facilitation of Development of orphan drugs and other Products; Implementation of the Orphan Drug act

Clinical Research Practices and Drug Regulatory Affairs, 1984
openaire   +1 more source

POSB270 Does Orphan Drug Status Confer Any Benefits for Products Undergoing HTA Appraisal By NICE in England?

Value in Health, 2022
G Foxon, P Craddy, C Wilson
openaire   +1 more source

Developments Related to Orphan Drug Products

American Journal of Health-System Pharmacy, 1983
openaire   +1 more source

Drug repositioning for orphan diseases

Briefings in Bioinformatics, 2011
Anil Jegga, Minlu Zhang, Yang Lun
exaly  

New products highlight ambiguity of orphan drug law

Nature Biotechnology, 2003
openaire   +1 more source

The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?

Health Policy, 2010
Youwen Zhou
exaly  

The Committee for Orphan Medicinal Products of the EMEA has granted orphan drug status to maribavir

Inpharma Weekly, 2007
openaire   +1 more source

Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU

European Journal of Clinical Pharmacology, 2012
Vittorio Bertele', Roberta Joppi, Bertele' Vittorio   +2 more
exaly  

Predictors of orphan drug approval in the European Union

European Journal of Clinical Pharmacology, 2008
, Leufkens Hubert G M
exaly  

The US Orphan Drug Programme 1983-1995

Pharmacoeconomics, 2012
Michael Manocchia
exaly